1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ABBVIE INC
Abbvie Inc XNYS: ABBV

AbbVie Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several ne...

Read More
228.18 1.17 (0.52%)
38.80% Gain from 52W Low
2.9M
XNYS Volume

XNYS 11 Mar, 2026 3:01 PM (EDT)

Watchlist

Portfolio

Alert
Dividend
AbbVie has an upcoming dividend of $1.73 per share due on 15 Apr 2026 See details
Durability score
Low Financial Strength
27.8 / 100
Valuation Score
Expensive Valuation
17.8 / 100
Momentum Score
Technically Neutral
58.8 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
249
1Yr Price target upside is 9%
29 analysts

8

S

8

W

2

O

1

T

SWOT Analysis

AbbVie Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..